Get the Stockscreener App
0.0941
7.75%
-0.0079
After Hours:
.10
0.0059
+6.27%
Quince Therapeutics Inc stock is traded at $0.0941, with a volume of 15.15M.
It is down -7.75% in the last 24 hours and down -32.06% over the past month.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
See More
Previous Close:
$0.102
Open:
$0.09435
24h Volume:
15.15M
Relative Volume:
0.26
Market Cap:
$5.24M
Revenue:
-
Net Income/Loss:
$-56.98M
P/E Ratio:
-0.0772
EPS:
-1.2189
Net Cash Flow:
$-38.98M
1W Performance:
+7.30%
1M Performance:
-32.06%
6M Performance:
-94.16%
1Y Performance:
-92.98%
1-Day Range:
$0.0904
$0.1027
1-Week Range:
$0.08
$0.1112
52-Week Range:
$0.08
$4.5499
Quince Therapeutics Inc Stock (QNCX) Company Profile
Name
Quince Therapeutics Inc
Sector
Industry
Phone
415-910-5717
Address
611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO
Compare QNCX vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QNCX
Quince Therapeutics Inc
|
0.0941 | 5.68M | 0 | -56.98M | -38.98M | -1.2189 |
VRTX
Vertex Pharmaceuticals Inc
|
453.74 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
756.73 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.16 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
692.83 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
147.60 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Quince Therapeutics Inc Stock (QNCX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-26 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Aug-05-25 | Initiated | Citizens JMP | Mkt Outperform |
| Mar-24-25 | Initiated | Oppenheimer | Outperform |
Quince Therapeutics Inc Stock (QNCX) Latest News
Highs Report: Can Quince Therapeutics Inc sustain its profitabilityDollar Strength & AI Driven Price Predictions - baoquankhu1.vn
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Quince Therapeutics stock extends rally on strategic review - MSN
Published on: 2026-03-22 07:39:28 - baoquankhu1.vn
Quince Therapeutics receives Nasdaq notices for bid price and market value - Investing.com UK
Form 8K Quince Therapeutics Inc For: 20 March By Investing.com - Investing.com
Quince Therapeutics Faces Nasdaq Listing Compliance Deficiencies - TipRanks
Quince Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Quince Therapeutics (QNCX) hit with dual Nasdaq listing deficiency notices - Stock Titan
QNCX stock down 9.59% intraday (NASDAQ) March 20 2026: earnings week in focus - Meyka
Quince Therapeutics Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Bear Alert: Is now the right time to enter Quince Therapeutics IncWeekly Trade Analysis & Technical Confirmation Trade Alerts - baoquankhu1.vn
QNCX Quince Therapeutics (NASDAQ) $0.099 intraday 18 Mar 2026: earnings Mar 23 could reset outlook - Meyka
Stock Analysis: How cyclical is Quince Therapeutics Incs revenue stream2026 Market Mood & High Accuracy Trade Alerts - baoquankhu1.vn
Quince Therapeutics (QNCX) Expected to Announce Quarterly Earnings on Monday - Defense World
Quince Therapeutics (QNCX) price target decreased by 33.33% to 4.08 - MSN
What sparked Quince Therapeutics (QNCX) stock to rise 53% after hours - MSN
Can Quince Therapeutics Inc. stock rebound after recent weaknessJuly 2025 Selloffs & Entry Point Confirmation Signals - Naître et grandir
Aug PreEarnings: Is now the right time to enter Quince Therapeutics IncTrend Reversal & Community Trade Idea Sharing Platform - baoquankhu1.vn
Group One Trading LLC holds 5.94M shares in Quince (QNCX) filing - Stock Titan
Quince Therapeutics, Inc. (NASDAQ:QNCX) Given Average Recommendation of “Reduce” by Analysts - Defense World
Trading Recap: Is Quince Therapeutics Inc stock overvalued or fairly priced2025 Technical Overview & Verified Short-Term Plans - baoquankhu1.vn
QNCX SEC FilingsQuince 10-K, 10-Q, 8-K Forms - Stock Titan
QNCX Should I Buy - Intellectia AI
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
QNCX Technical Analysis & ETF Price Forecast - Intellectia AI
What Does the Market Think About Quince Therapeutics Inc? - Benzinga
Can Quince Therapeutics Inc. stock surprise with earnings upsideJuly 2025 WrapUp & Consistent Return Investment Signals - mfd.ru
Published on: 2026-02-20 10:05:26 - mfd.ru
Why is QNCX stock up 60% pre-market after a near-total wipeout? - MSN
What Sparked Quince Therapeutics (QNCX) Stock To Rise 53% After Hours - Sahm
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Market Overview: What is the long term forecast for Warner Music Group Corp stock2025 Earnings Impact & Stepwise Trade Signal Guides - baoquankhu1.vn
Quince Therapeutics stock plunges as filing shows reverse merger plans, bankruptcy risks - MSN
Sell Signal: Is now the right time to enter Quince Therapeutics IncEarnings Overview Report & Smart Money Movement Tracker - baoquankhu1.vn
Quince Therapeutics Pursues Reverse Merger Amid Restructuring Effort - The Globe and Mail
Quince Therapeutics Stock Plunges As Filing Shows Reverse Merger Plans, Bankruptcy Risks - Sahm
3 Penny Stocks to Watch Now, 2/13/26 - TipRanks
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Quince Therapeutics engages LifeSci Capital for strategic alternatives - marketscreener.com
Quince Therapeutics Inc (QNCX) Stock Price, Quote, News & History - Benzinga
Quince Therapeutics stock plummets after revealing strategic alternatives By Investing.com - Investing.com Canada
Quince Therapeutics stock plummets after revealing strategic alternatives - Investing.com
Quince TherapeuticsOn Feb 9, Engaged Lifesci Capital For Strategic AlternativesSEC Filing - TradingView
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Best Penny Stocks To Watch Now – February 10th - Defense World
Small Cap Stocks To Follow Now – February 10th - Defense World
Quince Therapeutics Inc Stock (QNCX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.04%
0.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):